BlueRock Therapeutics
Highly Engaged Employees
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
238 Main St Ste 3, Cambridge, Massachuse...Phone Number
(857) 299-7589Website
www.bluerocktx.comRevenue
$42.3 MillionIndustry
About BlueRock Therapeutics
BlueRock Therapeutics, a wholly owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics' cell+gene platform harnesses the power of cells for new medicines across neurology, cardiology and immunology indications. BlueRock Therapeutics' cell differentiation technology recapitulates the cell's developmental biology to produce authentic cell therapies, which are further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. BlueRock's culture is defined by scientific innovation, highest ethical standards and an urgency to bring transformative treatments to all who would benefit.Explore more
SIC Code 87,873NAICS Code 54,541Show moreBlueRock Therapeutics Org Chart
Compare Similar Companies to BlueRock Therapeutics
Compare insights from companies similar to BlueRock Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BlueRock Therapeutics Tech Stack
A closer look at the technologies used by BlueRock Therapeutics
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BlueRock Therapeutics
Sign Up For FreeTo access detailed company insights
BlueRock Therapeutics, a wholly owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics' cell+gene platform harnesses the power of cells for new medicines across neurology, cardiology and immunology indicati... Read More
